Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMounjaro is taken once a week, meaning the gap between doses is exactly seven days. That interval is fixed by the licensed schedule: each dose needs a full week to work before the next one is due. Missing that rhythm, or cutting it short, is something to discuss with your prescriber rather than self-correct. Mounjaro is a prescription-only medicine requiring clinical assessment before it can be supplied, and any changes to your personal schedule should be made with your prescribing team. The NHS guidance on tirzepatide sets this out clearly for patients.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The answer sits in how tirzepatide (the medicine inside Mounjaro) moves through the body. Its half-life is roughly five days, which means a meaningful amount is still circulating when you inject the next dose. Seven days gives the previous pen's medicine time to work, while keeping blood levels stable enough to maintain the appetite-reducing and metabolic effects that make treatment effective.
Going shorter than seven days on a regular basis risks stacking doses, which is associated with a higher chance of nausea and other gastrointestinal side effects rather than faster weight loss. Going longer, equally, lets levels dip more than intended. If you want to understand how long between Mounjaro doses is considered safe and why that window matters, the full reasoning is worth reading before adjusting your schedule. Seven days is the number the clinical programme was built around, the SURMOUNT-1 trial that underpins the UK licence used exactly that schedule across thousands of participants. That evidence base is why the prescriber can't simply adjust the interval to suit convenience.
Worth knowing: the pen itself contains four weekly doses. If you want to understand exactly how many doses a Mounjaro pen holds and how that maps to your supply, that detail matters for planning ahead.
Yes, occasionally and within limits. The patient information leaflet allows a one-off shift of up to two days in either direction, as long as the gap between any two consecutive injections stays at least four days. So if your usual day is a Monday and you want to move to a Wednesday once, that's within the stated allowance. What you cannot do is routinely inject every five days, that turns an occasional flexibility into a shorter schedule, which isn't the licensed approach.
Practical timing catches a lot of people out. Holidays, bank holidays, or even just realising on a Tuesday night that your Monday dose is still in the fridge happen to almost everyone at some point. The answer is straightforward: check the gap, inject if it's been at least four days since the last one, then return to your usual day the following week. If the gap has stretched considerably beyond seven days, contact your prescribing team rather than guessing. Our frequently asked questions cover some of these timing scenarios, but your prescriber is the right person for anything specific to your situation.
One thing that catches people out more than expected: payday cycles and monthly delivery habits don't align neatly with a seven-day injection schedule. A four-week pen covers 28 days; order on the right day each month and the rhythm tends to hold.
The frequency stays the same (once weekly, seven days apart) but the dose level increases in steps, typically every four weeks at the prescriber's direction. Mounjaro is available in six strengths in the UK: 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, and 15 mg. The starting point is always 2.5 mg; its job is to let your system settle into once-weekly injections before the therapeutic work begins.
At each stage, the prescriber looks at how you've been getting on (side effects, tolerability, any relevant health changes) before agreeing to move up. If 2.5 mg has been difficult, staying at that level longer is sometimes the right call. The concept of finding your optimal dose is worth reading about if you're thinking ahead about where treatment might take you. You can also read more about the 5 mg strength specifically if you're approaching or currently at that step.
The full picture of how this medicine works (mechanism, eligibility, and what to expect) is covered on the Mounjaro treatment page. For context on the cost of ongoing treatment, the cost and pricing page lays out what a legitimate private prescription typically involves.
First, don't inject a double dose to compensate. That's explicitly not recommended and won't speed up results, it will increase the likelihood of nausea and other gastrointestinal discomfort. Instead, check how many days have passed since your last injection.
If it has been fewer than four days, wait until the four-day minimum has elapsed, inject then, and move your schedule to that new day going forward. If it has been more than four days but less than the point where you're unsure whether your pen is still safe to use, inject as soon as you remember and reset from there. If significant time has elapsed (for instance if illness or travel meant you missed a week or more) your prescribing team at our support team or your prescriber is the right first call. They can look at your full picture, including whether a dose step-down to manage restarting would be sensible.
The BNF entry for tirzepatide and the patient information leaflet that comes with your pen both contain the specific missed-dose instructions in full. When in doubt, read the leaflet first and call your prescriber second, not the other way around.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.